Experimentally, miR-125-induced down-regulation of ERBB2 and ERBB3 has been uncovered to reduce cell motility and invasiveness of numerous cancers, including breast cancer [22] and endometrial cancer [72]. This evidence concerns the gene ERBB3 and breast cancer.